Terms: = Lymphoma AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Prognosis
67 results:
1. Pre-treatment [
Chen J; Zhao Y
Hematology; 2024 Dec; 29(1):2325317. PubMed ID: 38465661
[TBL] [Abstract] [Full Text] [Related]
2. MYCT1 inhibits hematopoiesis in diffuse large B-cell lymphoma by suppressing RUNX1 transcription.
Liang Y; Wei X; Yue PJ; Zhang HC; Li ZN; Wang XX; Sun YY; Fu WN
Cell Mol Biol Lett; 2024 Jan; 29(1):5. PubMed ID: 38172714
[TBL] [Abstract] [Full Text] [Related]
3. Impact of baseline and interim quantitative PET parameters on outcomes of classical Hodgkin lymphoma.
Santos FM; Marin JFG; Lima MS; Silva-Junior WF; Alves LBO; Moreira FR; Velasques RD; Atanazio MJ; Maia ACA; Buchpiguel CA; Buccheri V; Rocha V
Ann Hematol; 2024 Jan; 103(1):175-183. PubMed ID: 37796339
[TBL] [Abstract] [Full Text] [Related]
4. Stacking Ensemble Learning-Based [
Zhao S; Wang J; Jin C; Zhang X; Xue C; Zhou R; Zhong Y; Liu Y; He X; Zhou Y; Xu C; Zhang L; Qian W; Zhang H; Zhang X; Tian M
J Nucl Med; 2023 Oct; 64(10):1603-1609. PubMed ID: 37500261
[TBL] [Abstract] [Full Text] [Related]
5. Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma.
Mistry V; Scott JR; Wang TY; Mollee P; Miles KA; Law WP; Hapgood G
Cancer Imaging; 2023 Jan; 23(1):11. PubMed ID: 36694244
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic role of pretreatment
Yang T; Liu S; Zuo R; Liang H; Xu L; Wang Z; Chen X; Pang H
BMC Med Imaging; 2023 Jan; 23(1):12. PubMed ID: 36681824
[TBL] [Abstract] [Full Text] [Related]
7. Interim FDG
Duarte S; Roque A; Saraiva T; Afonso C; Marques BA; Lima CB; Neves D; Lai AC; Costa G; Cipriano A; Geraldes C; Ruzickova L; Carda JP; Gomes M
Clin Lymphoma Myeloma Leuk; 2023 Feb; 23(2):e107-e116. PubMed ID: 36567213
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic Value of
Michaud L; Bantilan K; Mauguen A; Moskowitz CH; Zelenetz AD; Schöder H
J Nucl Med; 2023 Apr; 64(4):536-541. PubMed ID: 36549918
[TBL] [Abstract] [Full Text] [Related]
9. An integrative non-invasive malignant brain tumors classification and Ki-67 labeling index prediction pipeline with radiomics approach.
Zhang L; Liu X; Xu X; Liu W; Jia Y; Chen W; Fu X; Li Q; Sun X; Zhang Y; Shu S; Zhang X; Xiang R; Chen H; Sun P; Geng D; Yu Z; Liu J; Wang J
Eur J Radiol; 2023 Jan; 158():110639. PubMed ID: 36463703
[TBL] [Abstract] [Full Text] [Related]
10. Inhibition of USP1 reverses the chemotherapy resistance through destabilization of max in the relapsed/refractory B-cell lymphoma.
Li XY; Wu JC; Liu P; Li ZJ; Wang Y; Chen BY; Hu CL; Fei MY; Yu PC; Jiang YL; Xu CH; Chang BH; Chen XC; Zong LJ; Zhang JY; Fang Y; Sun XJ; Xue K; Wang L; Chen SB; Jiang SY; Gui AL; Yang L; Gu JJ; Yu BH; Zhang QL; Wang L
Leukemia; 2023 Jan; 37(1):164-177. PubMed ID: 36352191
[TBL] [Abstract] [Full Text] [Related]
11. Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinib.
Kittai AS; Huang Y; Beckwith KA; Bhat SA; Bond DA; Byrd JC; Goldstein D; Grever MR; Miller C; Rogers KA; Yano M; Woyach JA
Am J Hematol; 2023 Jan; 98(1):56-65. PubMed ID: 36216791
[TBL] [Abstract] [Full Text] [Related]
12. [The prognosis Assessment Value of Interim
Peng XJ; Kou Y; Yu SS; Yao YT; Jiang XM; You JH; Zhang ZH; Chen SR; Jiang X; Cheng ZZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1440-1445. PubMed ID: 36208247
[TBL] [Abstract] [Full Text] [Related]
13. PET/CT Evaluation of the Effect of Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of T-Cell Lymphoblastic lymphoma.
Zhao J; Guo X; Ma L; Zheng M; Guan T; Su L
Contrast Media Mol Imaging; 2022; 2022():6057017. PubMed ID: 36072622
[TBL] [Abstract] [Full Text] [Related]
14. Baseline 18 F-FDG PET/CT May Portend the prognosis of Patients With Waldenström Macroglobulinemia/Lymphoplasmacytic lymphoma After First-Line Treatment.
Pan Q; Cao X; Luo Y; Li J; Li F
Clin Nucl Med; 2022 Nov; 47(11):954-960. PubMed ID: 35961637
[TBL] [Abstract] [Full Text] [Related]
15. [Pretreatment evaluation of
Peng P; Wu N; Tao XL; Liu Y; Lyu L; Cheng X
Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):370-376. PubMed ID: 35448927
[No Abstract] [Full Text] [Related]
16. [Prognostic evaluation value of (18)F-FDG PET-CT in Hodgkin's lymphoma after treatment].
Wan H; Liu P; Liang Y; Jiang SY; Lyu L; Zhang ZW; Wu N; Liu Y
Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1275-1281. PubMed ID: 34915636
[No Abstract] [Full Text] [Related]
17. Radiomic Features of
Zhou Y; Zhu Y; Chen Z; Li J; Sang S; Deng S
Contrast Media Mol Imaging; 2021; 2021():6347404. PubMed ID: 34887712
[TBL] [Abstract] [Full Text] [Related]
18. [Prognostic Value of
Su JM; Zheng QZ; Huang WR; Deng J; Wu J; Lu HQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1181-1186. PubMed ID: 34362500
[TBL] [Abstract] [Full Text] [Related]
19. 18F-FDG cerebellum/liver index as a prognostic factor for progression-free survival in diffuse large B-cell lymphoma.
Morland D; Zizi G; Godard F; Gauchy AC; Durot C; Hoeffel C; Delmer A; Papathanassiou D; Durot E
Ann Nucl Med; 2021 Jul; 35(7):785-793. PubMed ID: 34031852
[TBL] [Abstract] [Full Text] [Related]
20. Expressions of Putative Cancer Stem Cell Markers, CD44 and CD133, are Correlated with Pathological Tumour Stage in Gastric Adenocarcinoma.
Duzcu SE; Astarci HM; Tunc N; Boran C
J Coll Physicians Surg Pak; 2021 May; 31(5):553-558. PubMed ID: 34027868
[TBL] [Abstract] [Full Text] [Related]
[Next]
